Search by Drug Name or NDC

    NDC 50383-0705-30 Lorazepam 2 mg/mL Details

    Lorazepam 2 mg/mL

    Lorazepam is a ORAL CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is LORAZEPAM.

    Product Information

    NDC 50383-0705
    Product ID 50383-705_9ddced20-77c8-4183-b223-4d0389bef41a
    Associated GPIs 57100060001320
    GCN Sequence Number 016363
    GCN Sequence Number Description lorazepam ORAL CONC 2 MG/ML ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 19601
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Generic
    Proprietary Name Lorazepam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lorazepam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CONCENTRATE
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name LORAZEPAM
    Labeler Name Akorn
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA200169
    Listing Certified Through 2024-12-31

    Package

    NDC 50383-0705-30 (50383070530)

    NDC Package Code 50383-705-30
    Billing NDC 50383070530
    Package 1 BOTTLE in 1 CARTON (50383-705-30) / 30 mL in 1 BOTTLE
    Marketing Start Date 2012-01-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.57736
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description LORAZEPAM 2 MG/ML ORAL CONCENT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis